Early-onset neurodegeneration with brain iron accumulation due to PANK2 mutation

Daniela Rossi1, Elisa De Grandis, Chiara Barzaghi

  • 1Child Neurology and Psychiatry Unit, G. Gaslini Institute, Genova, Italy. danielapaolarossi@fastwebnet.it

Brain & Development
|October 18, 2011
PubMed
Abstract

Insights

Pantothenate kinase-associated neurodegeneration (PKAN) can present with subtle early signs, including developmental delay and specific MRI findings. Early diagnosis of this PANK2 gene disorder is crucial for potential therapeutic interventions in young children.

Area of Science:

  • Neurogenetics
  • Pediatric Neurology
  • Neuroimaging

Background:

  • Pantothenate kinase-associated neurodegeneration (PKAN) is a rare, inherited neurodegenerative disorder.
  • Mutations in the PANK2 gene are the primary cause of PKAN.
  • Characteristic brain MRI findings include the "eye-of-the-tiger" sign in the globus pallidus.

Observation:

  • A case study of a young boy with early-onset neurodegeneration and brain iron accumulation is presented.
  • Initial presentation at 2 years 10 months included developmental delay and toe-walking.
  • Brain MRI revealed isolated T2 hyperintensity in the globus pallidi.

Findings:

  • Over one year, the patient developed mild dystonia and characteristic T2*-weighted MRI changes (low signal areas in globus pallidi).
  • Genetic analysis confirmed a homozygous PANK2 gene mutation, establishing the diagnosis of PKAN.
  • This highlights a potential early MRI signature preceding overt "eye-of-the-tiger" sign.

Implications:

  • PKAN diagnosis should be considered in young children with nonspecific neurological symptoms and suggestive MRI findings.
  • Early identification is critical as therapeutic options may be more effective in paucisymptomatic individuals.
  • This case underscores the importance of genetic testing for neurodegenerative disorders with iron accumulation.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...